Stablecoin Development Corp.
SDEV | NYSE
$0.98
-$0.10 (-9.26%)
At close: Oct 30, 2026, 3:59 PM ET
$1.00
+$0.02 (+2.04%)
Pre-market:
Nov 2, 2026, 4:57 AM ET
Company Profile
Stablecoin Development Corp. specializes in manufacturing and distributing eye and skin health solutions that have undergone rigorous scientific development and proven efficacy in clinical settings. Their product portfolio features prominent brands such as Avenova, NeutroPhase, and DERMAdoctor. This enterprise was established on January 19, 2000, and its main office is situated in Emeryville, California.
Key Executives
| Name | Position |
|---|---|
| Michael Kazley | Chairman & CEO |
| Henry Blynn | Chief Operating Officer |
| Tommy | CFO & Treasurer |
Stablecoin Development Corp.
| Country | United States |
| IPO Date | Oct 26, 2007 |
| Industry | Medical - Pharmaceuticals |
| Sector | Healthcare |
| Employees | 4 |
| CEO | Michael Kazley |
Contact Details
2000 Powell Street Emeryville,
California 94608 United States
Stock Details
| Ticker Symbol | SDEV |
| Exchange | AMEX |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001389545 |
| CUSIP Number | 66987P508 |
| ISIN Number | US66987P5089 |
| SIC Code | n/a |
Add to Watchlist
Select watchlists to add or remove SDEV